SUMMARY Fibrin sealant is used to close perforated or preperforated corneal ulcers. In addition to the usual advantages of cyanoacrylates it is degraded physiologically and provides a good support for corneal healing. Corneal grafting can be avoided when contraindicated or postponed when conditions allow. This technique has been successful in nine eyes of eight patients.
ever their cause. The most commonly used treatment is emergency penetrating keratoplasty, but the poor visual prognosis for these emergency grafts requires other therapeutic solutions. The highly hydrophilic therapeutic lens can be used only for perforations of very small diameter.
The deposit of a layer of fibrin on the surface of the ulcer causes the anterior chamber to be closed immediately, with the hope that the cornea will subsequently heal. This avoids the need for grafts, which may fail if performed under unfavourable conditions, such as sicca syndrome or pemphigoid disease.
Materials and methods
The tissue adhesive used is Tisseel (Immuno France). Its action is the result of the interaction of two solutions. The first is an adhesive solution containing: (1) human fibrinogen freeze-dried at 30 times plasma concentration (90% proteins); (2) factor XIII, a fibrin-stabilising factor extracted from human plasma at 10 times plasma concentration (10 U/ml); (3) fibronectin (5% proteins); (4) low concentration plasminogen (0.13 g/l); (5) albumin (3% proteins); (6) aprotinin, a protease inhibitor of bovine origin at a concentration of 3000 UK. The second is a catalyst formed from a mixture of two solutions: (1) Thombin is used at a 500-U-NIH/mi concentration to ensure rapid setting. The two previously prepared solutions are applied either simultaneously via a single mixing needle (a technique possible thanks to the Duplojet device delivered with the kit) or successively, when the fibrin solution should be applied first, as it is more viscous and less likely to run. We ourselves prefer simultaneous application, as it provides both more homogeneous polymerisation and the optimal concentration ratio for the different compounds.
After two minutes' setting the tissue adhesive will have extended considerably beyond the edges of the ulcer and the excess must be cut to a smooth bevel. This is an easy task, as the tissue adhesive has very little adherence to the epithelium of the healthy cornea, where there is no collagen, the substance with which fibrin crosslinks.
A soft lens is applied in order to limit any shearing forces due to palpebral movements which could remove the sealant plug.
A flat anterior chamber can be deepened by a viscous substance such as sodium hyaluronate prior to the use A 51-year-old woman with Sjogren's syndrome, who had received no ophthalmic care. She had perfectly symmetrical perforations of both corneas, and stated she had had them for three weeks. Both perforations were round, with a punch diameter of 2.5 mm, paracentral and temporal, with an iris plug in the ulcer, positive Seidel's test, and a collapsed anterior chamber (Fig. 1) . The fibrin sealant was applied at the site of perforation, and the anterior chamber was deepened by limbic puncture after sealing, since the viscous substance would not have remained in the anterior chamber. Seventy-two hours later the sealant plugs had completely dissolved, making it necessary to reapply the sealant. A bandage lens was applied. To avoid rapid fibrinolysis, aprotinin was instilled six times a day. The sealant remained one month (Fig.  2) , leaving a bilateral corneal leucoma. The anterior chamber was quiet. In both eyes there was a very slight filiform iridocorneal synechia at the perforation site; this would have been insufficient to close a perforation of that size. Two months later the corrected visual acuity was 20/30 right eye, 20/25 left eye, with an ocular pressure of 10 mmHg in both eyes; the scar was stable and no graft was advised (Fig. 3) .
Four months later the visual acuity was 20/60 right eye, 20/25 left eye. New stromal inflammation had appeared in previously healthy areas but was stopped with the usual medication. CASE 7 A 66-year-old man, suffering from a rosacea presented with an ulcer of the right eye which had perforated 7 days previously. This perforation, which was a clear 2 mm hole, temporal paracentral, was blocked by an iris plug. Fibrin sealant was placed in the perforation and the anterior chamber was reformed with sodium hyaluronate introduced by limbic puncture. A bandage lens was applied and Iniprol was instilled 6 times a day. Complete healing ensued after one month. The visual acuity was 20/60 and a graft was not advised. CASE 8 A 131/2-year-old child was suffering from corneal anaesthesia and facial paresis owing to a lesion of the posterior fossa. An ulcer, which had started a month earlier, had perforated. The lens was blocking the perforation. Fibrin sealant was applied, and the anterior chamber was reformed with sodium hyaluronate. A partial tarsorrhaphy was also performed, and Iniprol was instilled six times a day. After two months the ulcer seemed to be definitely healed.
Discussion
The idea of using surgical glue in the treatment of perforated or preperforated ulcers is not new. As early as the 1960s surgical sealants and their various applications were proposed.'2 A study of cyanoacrylates revealed that their properties depend on the chemical variety used. These sealants are known to have anti-infectious properties inversely proportional to the length of their constituent monomers3 and an inhibiting effect on corneal necrosis.4 Their ocular toxicity, however, is variously assessed. Some workers consider cyanoacrylates are responsible for corneal inflammation, neovascularisation of the stroma, and inflammatory reactions in the anterior chamber,56 while others consider that they are well tolerated.78
In fact, tolerance to cyanoacrylate varies according to the quantity of glue. When very little is used, the inflammatory reaction and vascularisation are minimal, but when the glued area covers as much as a quarter of the cornea the result is poor. 9 For a long time the requirement not to introduce this glue into the anterior chamber meant that cyanoacrylates were used for small diameter (1 mm It has also been proved that the use of fibrin seal does not increase the risk of non-A non-B hepatitis. ' In our experience, this simple technique has made it possible to avoid keratoplasty in nine patients, for four of whom a severe sicca syndrome meant a very poor prognosis for any graft, even after the perforation had completely healed. We have never encountered any problems with infection of the treated ulcer, nor has any residual inflammation of the anterior chamber been observed after resorption of the inflammatory reaction due to the perforation.
The technique is simple, non-invasive, and fully reversible. It has the major advantage over synthetic sealants of providing a true support and helping the cornea to heal. The clot of fibrin applied degrades very gradually and is replaced by fibrosis, of which it forms the initial web. In the event of failure it in no way hinders keratoplasty and can even improve the prognosis. When successful the perforation is replaced by a corneal scar which, if not on the visual axis, or if a graft is contraindicated, enables keratoplasty to be definitely avoided.
The use of this organic sealant has in addition to the usual advantages of surgical sealants those of being well tolerated, degraded by the physiological and non-inflammatory mechanism of fibrinolysis, and of providing a good support for corneal healing.
